|
|||||
|
|
Endometrial safety of third generation aromatase inhibitors versus tamoxifen in breast cancer patients |
|
| Authors: | L MORALES† D TIMMERMAN† P NEVEN†‡ & R PARIDAENS‡ |
| Institution: | Departments of Medical Oncology;, Obstetrics and Gynecology;, and Multidisciplinary Breast Center, University Hospital Gasthuisberg, Leuven, Belgium |
| Abstract: | |
| Keywords: | aromatase inhibitors breast cancer endometrium tamoxifen uterine changes |